News | December 26, 2025
The decision is based on robust clinical evidence from the VOYAGE and EXCURSION studies
The therapy targets the LRRC15 protein and is designed for enhanced tumor penetration and differentiated anti-tumor activity in solid tumors with the highest unmet needs.
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
The initiative is focused on a problem that continues to plague cancer outcomes in India
Company acquires People Tree Hospital Yeshwanthpur for Rs. 430 crore
The state-of-the-art facility is expected to be commissioned over the next three years
GS-098, a first-in-class, humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor, is designed to rapidly block the pathogenic activity of thyroid-stimulating autoantibodies
The center will deliver Certified Pre-Owned instruments restored to factory-grade standards and backed by Agilent Standard Warranty
The move strengthens GBL’s clinical-stage presence in the United States
Subscribe To Our Newsletter & Stay Updated
